Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 26:1-10.
doi: 10.1159/000541029. Online ahead of print.

Defining Success in the Delivery of Fertility-Related Care for Patients with Differences of Sex Development

Affiliations

Defining Success in the Delivery of Fertility-Related Care for Patients with Differences of Sex Development

Tara Streich-Tilles et al. Horm Res Paediatr. .

Abstract

Introduction: Individuals with differences of sex development (DSD) experience complex, often competing, medical and psychosocial challenges surrounding fertility. The study aimed to characterize how "success" in fertility-related care is conceptualized and attained among individuals with a DSD, their parents or caregivers, healthcare providers, and other stakeholders.

Methods: As part of a larger study, DSD stakeholders (n = 110) participated in semi-structured interviews covering the clinical care of patients with DSD. Primary questions included "What is a successful outcome in DSD care?" and "How do you achieve it?" with fertility as either a spontaneous or suggested topic of discussion. Transcripts were analyzed utilizing a phenomenological approach. This analysis focuses on the extracted themes related to fertility.

Results: Fertility was discussed by 19/24 individuals with DSD, 12/19 parents or caregivers, 35/37 healthcare providers, and 19/30 other stakeholders. Components of successful fertility-related care included (1) specific discussions surrounding the relationship between DSD and fertility potential, options for fertility preservation, and options for non-biologic parenthood; (2) early and repeated introduction of these topics; and (3) consideration of age, developmental maturity, and cultural context on decisions around fertility. Challenges included the lack of fertility outcome data in this population and the irreversibility of gonadectomy. Trade-offs identified included anatomic typicality versus function, fertility preservation versus cancer risk reduction, and balancing the different priorities of stakeholders.

Discussion/conclusions: A wide range of DSD stakeholders highlighted the importance of addressing fertility concerns in achieving favorable outcomes for individuals with DSD. These stakeholder perspectives should inform fertility-related education, shared decision-making processes, and clinical care.

Keywords: Differences of sex development; Disorders of sex development; Fertility; Qualitative research.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: E.M.W. is the paid Executive Director of Accord Alliance. The authors have no other conflicts of interest to declare.

References

    1. Lee PA, Houk CP, Ahmed SF, Hughes IA, International Consensus Conference on Intersex. Consensus statement on management of intersex disorders. Pediatrics. 2006. Aug;118(2):e488–500. - PubMed
    1. Lee PA, Nordenstrom A, Houk CP, Ahmed SF, Auchus R, Baratz A, et al. Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr. 2016;85(3):158–80. - PubMed
    1. Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, et al. Congenital adrenal hyperplasia: current insights in pathophysiology, diagnostics, and management. Endocr Rev. 2022. Jan 12;43(1):91–159. - PMC - PubMed
    1. Herlin MK, Petersen MB, Brannstrom M. Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome: a comprehensive update. Orphanet J Rare Dis. 2020. Aug 20;15(1):214. - PMC - PubMed
    1. Mendonca BB, Gomes NL, Costa EM, Inacio M, Martin RM, Nishi MY, et al. 46,XY disorder of sex development (DSD) due to 17beta-hydroxysteroid dehydrogenase type 3 deficiency. J Steroid Biochem Mol Biol. 2017. Jan;165(Pt A):79–85. - PubMed